$1.6 billion PEXA acquisition given shareholder approval

$1.6 billion PEXA acquisition given shareholder approval

The consortium scooping up Brisbane tech-company PEXA has been given the green-light to go ahead with the acquisition.

The offer to acquire PEXA, made by a consortium comprised of Link Group, Commonwealth Bank, and Morgan Stanley Infrastructure, has been accepted by shareholdings representing more than 82 per cent of PEXA's issued capital.

The consortium will pay an enterprise value of $1.604 billion for PEXA.

Completion of the sale remains subject to a range of conditions precedent which are expected to take around two months to be met.

Link Group managing director John McMurtrie says the consortium is pleased with today's result.

"Link Group is pleased that, alongside its Consortium partners, it has been successful in acquiring PEXA," says McMurtrie.

"Alan Cameron, Marcus Price and the PEXA team have done an exceptional job of developing and delivering on the vision of an electronic conveyancing system for Australia. Since its initial investment in 2013 Link Group has supported PEXA and its achievements and we look forward to continuing to work with management as the PEXA rollout continues."

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Advertisement

Related Stories

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Federal Court finds Google misled consumers on data collection

Federal Court finds Google misled consumers on data collection

The Federal Court has found Google misled consumers about persona...

Redflow charging up ahead of next-gen battery launch

Redflow charging up ahead of next-gen battery launch

Redflow (ASX: RFX) is gearing up to launch the next generation of...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...